Amlodipine/therapeutic use; Angiogenesis Inhibitors/adverse effects; Antibodies, Monoclonal, Humanized/adverse effects; Antihypertensive Agents/therapeutic use; Calcium Channel Blockers/therapeutic use; Hypertension/drug therapy; Neoplasms/drug therapy; Vasodilator Agents/therapeutic use; Adult; Aged; Amlodipine/administration & dosage; Amlodipine/adverse effects; Antihypertensive Agents/administration & dosage; Antihypertensive Agents/adverse effects; Bevacizumab; Blood Pressure/drug effects; Calcium Channel Blockers/administration & dosage; Calcium Channel Blockers/adverse effects; Carcinoma, Non-Small-Cell Lung/drug therapy; Carcinoma, Non-Small-Cell Lung/secondary; Chi-Square Distribution; Colorectal Neoplasms/drug therapy; Colorectal Neoplasms/pathology; Drug Administration Schedule; Female; Humans; Hypertension/chemically induced; Hypertension/physiopathology; Lung Neoplasms/drug therapy; Lung Neoplasms/pathology; Male; Middle Aged; Neoplasms/metabolism; Neoplasms/pathology; Ovarian Neoplasms/drug therapy; Ovarian Neoplasms/pathology; Paris; Retrospective Studies; Time Factors; Treatment Outcome; Vascular Endothelial Growth Factor A/antagonists & inhibitors; Vascular Endothelial Growth Factor A/metabolism; Vasodilator Agents/administration & dosage; Vasodilator Agents/adverse effects